Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

A girl with symptoms like an autoimmune disorder actually had HIV and a fungal infection, which was hard to diagnose and treat, leading to her death.

Immune cells are crucial for hair growth and preventing hair loss.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Alopecia areata involves immune response and gene changes affecting hair loss.

New psoriasis treatments are effective but come with side effects and risks.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Hair loss treatment caused more hair loss in a man.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.